Protective Immunity after Natural Infection with Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) - Kentucky, USA, 2020.

Spicer, Kevin B; Glick, Connor; Cavanaugh, Alyson M; Thoroughman, Douglas

Spicer, Kevin B; Glick, Connor; Cavanaugh, Alyson M; Thoroughman, Douglas.

Afiliación

Spicer KB; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), USA; Kentucky Department for Public Health, USA. Electronic address: nyf2@cdc.gov.
Glick C; Kentucky Department for Public Health, USA.
Cavanaugh AM; Kentucky Department for Public Health, USA; Epidemic Intelligence Service, CDC, USA.
Thoroughman D; Kentucky Department for Public Health, USA; Career Epidemiology Field Officer Program, Center for Preparedness and Response, CDC, USA.

Int J Infect Dis ; 114: 21-28, 2022 Jan.

Article en En | MEDLINE | ID: mdl-34649001

Asunto(s)

COVID-19; SARS-CoV-2; Vacunas contra la COVID-19; Humanos; Kentucky/epidemiología; Casas de Salud

Palabras clave

COVID-19; COVID-19 risk factors for reinfection; SARS-CoV-2; protective immunity after natural infection; reinfection

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Int J Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article Pais de publicación: Canadá

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google